;

Articles Not Curated - Drug studies in animals
Last updated: 2025 Jul 18
Total hit(s): 1119
S.No.
1
40028815
Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models.
Hum Vaccin Immunother
2025 Dec
4.7
1
2
39635731
Nationwide seroprevalence of SARS-CoV-2 Delta variant and five Omicron sublineages in companion cats and dogs in the USA: insights into their role in COVID-19 epidemiology.
Emerg Microbes Infect
2025 Dec
5.84
1
3
40580492
Development of the coronavirus reverse genetic system: Core technology for pathogenesis mechanisms research and vaccine/drug development.
Virulence
2025 Dec
4.81
1
4
40632483
Epidemiology of suicides attempt by self-poisoning: the Pavia Emergency-Toxicologic Network experience before and after the COVID-19 pandemic years.
Intern Emerg Med
2025 Jul 9
2.1
1
5
40628911
ADME analysis, metabolic prediction, and molecular docking of lipoic acid with SARS-CoV-2 Omicron spike protein.
Sci Rep
2025 Jul 8
4.12
1
6
40619617
Engineered Dual-Function Antibody-Like Proteins to Combat SARS-CoV-2-Induced Immune Dysregulation and Inflammation.
Adv Sci (Weinh)
2025 Jul 6
1
7
40650237
Moloney Murine Leukemia Virus-like Nanoparticles Pseudo-Typed with SARS-CoV-2 RBD for Vaccination Against COVID-19.
Int J Mol Sci
2025 Jul 4
4.21
1
8
40539933
Protective efficacy of pDNA vaccine candidate against SARS-CoV-2 in Syrian golden hamsters.
J Drug Target
2025 Jul 2
8.7
1
9
40676448
Intranasal delivery of engineered anti-SARS-CoV-2 extracellular vesicles therapeutically represses lung infection and inflammation.
Drug Deliv Transl Res
2025 Jul 17
1
10
40670289
Oral Administration of Water-Soluble Curcumin Complex Prevents ARDS With the Potential for COVID-19 Treatment.
Phytother Res
2025 Jul 16
7.5
1
11
40594111
SARS-CoV-2 infection promotes lung thrombosis by inducing integrinbeta3 expression in vascular endothelial cells.
Sci Rep
2025 Jul 1
4.12
1
12
40595876
Development and evaluation of cepharanthine-beta-cyclodextrin inclusion complex oral tablets for prevention and treatment of COVID-19 lung injury.
Sci Rep
2025 Jul 1
4.12
1
13
40609745
SARS-CoV-2-encoded miR-nsp3-3p promotes pulmonary fibrosis by inhibiting expression of ALCAM.
Virol Sin
2025 Jul 1
2.27
1
14
40586690
Deep Sequencing Reveals Dual Evolution of SARS-CoV-2: Insights Into Defective Genomes From Wuhan-Hu-1 Variants to Omicron Subvariants.
J Med Virol
2025 Jul
2.07
1
15
40318419
Interference between SARS-CoV-2 and influenza B virus during coinfection is mediated by induction of specific interferon responses in the lung epithelium.
Virology
2025 Jul
2.819
1
16
40482468
An mRNA vaccine encoding the SARS-CoV-2 Omicron XBB.1.5 receptor-binding domain protects mice from the JN.1 variant.
EBioMedicine
2025 Jun 6
6.49
1
17
40666984
PUM2 binds SARS-CoV-2 RNA and PUM1 mildly reduces viral RNA levels, but neither protein affects progeny virus production.
bioRxiv
2025 Jun 24
- n/a -
1
18
40585204
Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory Benefit.
Res Sq
2025 Jun 20
- n/a -
1
19
40570554
Dihydrotanshinone I targets the spike N-terminal domain to inhibit SARS-CoV-2 entry and spike-induced inflammation.
Phytomedicine
2025 Jun 17
7.2
1
20
40547706
In Silico Discovery of a Novel Antiviral Scaffold for SARS-CoV2 Targeting the Spike Glycoprotein through the Fatty Acid Binding Pocket.
ACS Omega
2025 Jun 17
2.55
1
21
40500288
Lipid Nanoparticle Development for A Fluvid mRNA Vaccine Targeting Seasonal Influenza and SARS-CoV-2.
NPJ Vaccines
2025 Jun 11
4.98
1
22
40498855
Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primates.
Sci Transl Med
2025 Jun 11
11.64
1
23
40254136
Lipid nanoparticles target neutrophils to reduce SARS-CoV-2-induced lung injury and inflammation.
J Control Release
2025 Jun 10
15.5
1
24
40442985
Pathological Glucose Levels Enhance Entry Factor Expression and Hepatic SARS-CoV-2 Infection.
J Cell Mol Med
2025 Jun
4.59
1
25
40522277
Papain-Like Protease of SARS-CoV-2 Induces Intestinal Inflammation via the ISG15 Pathway: Identification of Natural Compound Inhibitors.
J Med Virol
2025 Jun
2.07
1